Serratia Marcescens antibody

Catalog No. ABIN7865733

The Mouse Monoclonal anti-Serratia Marcescens antibody is suitable to detect Serratia Marcescens in samples from Serratia marcescens. It has been validated for IF, ELISA, ICC and IHC.

Quick Overview for Serratia Marcescens antibody (ABIN7865733)

Target: Serratia Marcescens

Reactivity: Serratia marcescens

Host: Mouse

Clonality: Monoclonal

Conjugate: This Serratia Marcescens antibody is un-conjugated

Application: Immunofluorescence (IF), ELISA, Immunocytochemistry (ICC), Immunohistochemistry (IHC)

Clone: EBS-I-105

Product Details anti-Serratia Marcescens Antibody

Purpose: anti-Serratia marcescens mouse monoclonal, EBS-I-105, purified

Purification: affinity chromatography

Immunogen: total sonicate of Serratia marcescens

Isotype: IgG3 kappa

Application Details

Application Notes:

ICC/IF_dilution: 1:100-1:200 (0.5-1.0 μg/mL)

IHC-frozen_dilution: 1:50-1:100 (1-2 μg/mL)

elisa_dilution: assay dependent

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 100 μg/mL

Buffer: PBS with 0.02 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: store at 2 - 8 °C

Target Details for Serratia Marcescens

Target: Serratia Marcescens

Target Type: Species

Background: Serratia marcescens is a species of Gram-negative bacteria in the family Enterobacteriaceae. It is a broad host range pathogen, and is also capable of opportunistic infections of humans. Some strains of S. marcescens are capable of producing a pigment called prodigiosin, which ranges in color from dark red to pale pink. S. marcescens is a rod shaped, motile organism and can grow in temperatures ranging from 5 - 40°C Celsius and in pH levels ranging from 5 to 9. S. marcescens is involved in hospital-acquired infections, particularly in urinary tract and wound infections. Serratia species cause 1.4% of nosocomial bloodstream infections with an associated mortality of 25% [in USA]. Most S. marcescens strains are resistant to several antibiotics because of the presence of R factors in plasmids. Positive control: S. marcescens extract or infected cells or tissue.